Back

Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Digging deeper into oral anticoagulants Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Giulia Renda

G. d Annunzio University, Chieti (Italy)

4 More presentations in this session

Presentation thumbnail
Mr M. Tarsillo (Wallingford, US)
Abstract Slides
Presentation thumbnail
Assistant Professor T. Moumneh (Tours, FR)
Abstract Slides
Presentation thumbnail
Doctor A. Shimizu (Kitakyushu, JP)
Abstract
Presentation thumbnail
Doctor D. Moreira (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Digging deeper into oral anticoagulants

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET
You may be interested in
thumbnail
Congress Session
The new frontier in oral anticoagulation: Factor XIa inhibitors
16 April 2023
thumbnail
Congress Presentation
Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
27 August 2021
thumbnail
Congress Presentation
Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study
1 September 2019
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources